Background: Extracorporeal photochemotherapy (EP) is used for the treatment of cutaneous
T-cell lymphoma (CTCL), progressive systemic sclerosis (PSS), pemphigus vulgaris, and …

Photopheresis, the process by which peripheral blood is exposed in an extracorporeal flow
system to photoactivated 8-methoxypsoralen (8-MOP), is a new treatment for disorders …

Although extracorporeal photochemotherapy (ECP) is reported to be effective for a wide
variety of diseases, such as cutaneous T cell lymphoma, autoimmune diseases, organ graft …

Photopheresis, the process by which peripheral blood is exposed in an extracorporeal flow
system to photoactivated 8-methoxypsoralen (8-MOP), is an effective new treatment for …

Photopheresis or extracorporeal photochemotherapy (ECP) is an immunomodulating
procedure that has been available for the treatment of cutaneous T‐cell lymphoma (CTCL) …

Background and Objective Extracorporeal photopheresis (ECP), an established modality for
cutaneous T‐cell lymphoma (CTCL) and graft‐versus‐host disease, involves ex vivo …

Extracorporeal photopheresis (ECP) is a leukapheresis-based therapy that uses 8-
methoxypsoralen and ultraviolet A irradiation. Used alone or in combination with biological …

Extracorporeal photopheresis (ECP) and psoralen plus ultraviolet A therapy (PUVA) are
widely accepted types of photochemotherapy used for the treatment of cutaneous T-cell …

Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy based upon pheresis of light‐sensitive cells. Whole blood is removed from patients …

Extracorporeal photochemotherapy was developed for treatment of cutaneous T-cell
lymphoma (CTCL). Several independent and multicenter trials using lymphapheresis with 8 …